TranS1 (OTCMKTS:BAXSQ) versus Nanovibronix (NASDAQ:FEED) Head-To-Head Contrast

Nanovibronix (NASDAQ:FEED) and TranS1 (OTCMKTS:BAXSQ) are both manufacturing companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

Valuation & Earnings

This table compares Nanovibronix and TranS1″s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nanovibronix	$2.69 million	1.17	-$3.70 million	($41.74)	-0.07
TranS1	N/A	N/A	N/A	N/A	N/A

TranS1 has lower revenue, but higher earnings than Nanovibronix.

Institutional & Insider Ownership

16.4% of Nanovibronix shares are held by institutional investors. 1.4% of Nanovibronix shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Nanovibronix and TranS1’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-275.12%	-24.78%	-19.24%
TranS1	N/A	N/A	N/A

Analyst Ratings

This is a summary of recent recommendations and price targets for Nanovibronix and TranS1, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
TranS1	0	0	0	0	0.00

Given TranS1’s higher possible upside, analysts plainly believe TranS1 is more favorable than Nanovibronix.

About Nanovibronix

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.

About TranS1

Baxano Surgical, Inc., formerly Baxano Inc. is a medical device company. The Company is focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. The Company markets the AxiaLIF pre-sacral access and interbody fusion system for single and two level lower lumbar fusion, the VEO lateral access and interbody fusion system, the iO-Flex set of flexible instruments used by surgeons during spinal decompression procedures, and the iO-Tome instrument for rapid and precise removal of bone, specifically the facet joints, a technique which is commonly performed in spinal fusion procedures. The Company’s other products include: Vectre facet screw system, Bi-Ostetic bone void filler, bowel retractors, discectomy tools, and a bone graft harvesting system that can be used to extract bone graft from the patient’s hip for use in fusion procedures.